COVID-19: Community Pharmacy Practice in Africa

Melody Okereke; Yusuff Adebayo Adebisi; Nzeribe Emmanuella; Hadi Mohammed  Jaber; Lilian Muthoni; Najim Ben Barka

doi:10.5812/ijhls.104517

COVID-19: Community Pharmacy Practice in Africa

authors:

Melody Okereke ^{1
, *} , Yusuff Adebayo Adebisi ² , Nzeribe Emmanuella ³ , Hadi Mohammed Jaber ⁴ , Lilian Muthoni ⁵ , Najim Ben Barka ⁶

1 Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria

2 Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria

3 Faculty of Pharmaceutical Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana

4 Faculty of Pharmaceutical Sciences, College of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone

5 School of Pharmacy, Kenyatta University, Nairobi, Kenya

6 Faculty of Pharmacy, University Science Technical and Technologies De Bamako, Bamako, Mali

International Journal of Health and Life Sciences: Vol.6, issue 2; e104517

published online: June 21, 2020

article type: Letter

received: May 12, 2020

revised: June 13, 2020

accepted: June 14, 2020

DOI: https://doi.org/10.5812/ijhls.104517

how to cite: Okereke M, Adebisi Y A, Emmanuella N, Jaber H M , Muthoni L, et al. COVID-19: Community Pharmacy Practice in Africa. J Health Rep Technol. 2020;6(2):e104517. https://doi.org/10.5812/ijhls.104517.

Keywords

Practice Pharmacy Community Pharmacists Africa Pandemic COVID-19 Lockdown

Footnotes

Authors' Contribution: Study concept and design: Melody Okereke, Nzeribe Emmanuella, Hadi Mohammed Jaber, Lilian Muthoni, and Najim Ben Barka. Drafting of the manuscript: Melody Okereke and Yusuff Adebayo Adebisi. Study supervision: Yusuff Adebayo Adebisi.
Conflict of Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding/Support: The author(s) received no financial support for the research, authorship, and/or publication of this article.

References

1.
Lucero-Prisno Iii DE, Adebisi YA, Micheal AI, Ukor NA. Letter to the editor: Pharmacy education in Africa. Int J Health Life Sci. 2019;5(1). e89009. https://doi.org/10.5812/ijhls.89009.
2.
Rutter V, Chan AHY, Tuck C, Bader L, Babar ZU, Bates I. Weaving the health and pharmaceutical care agenda through the themes of the commonwealth heads of government meeting (CHOGM), London 2018. J Pharm Policy Pract. 2018;11:10. [PubMed ID: 29651337]. [PubMed Central ID: PMC5896036]. https://doi.org/10.1186/s40545-018-0140-3.
3.
Miller S, Patel N, Vadala T, Abrons J, Cerulli J. Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. J Am Pharm Assoc (2003). 2012;52(6):763-7. [PubMed ID: 23229962]. https://doi.org/10.1331/JAPhA.2012.11003.
4.
Centre for Disease Control and Prevention. Place of influenza vaccination among adults -United States, 2010-11 Influenza Season. 2010, [cited 2020 Apr 29]. Available from: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6023a3.htm.
5.
Stergachis A, Garberson L, Lien O, D'Ambrosio L, Sangare L, Dold C. Health care workers' ability and willingness to report to work during public health emergencies. Disaster Med Public Health Prep. 2011;5(4):300-8. [PubMed ID: 22146669]. https://doi.org/10.1001/dmp.2011.77.
6.
International Pharmaceutical Federation (Health Advisory). Coronavirus 2019-nCoV outbreak. Information and interim guidelines for pharmacists and the pharmacy workforce 2020 The Netherlands. 2020. Available from: https://www.fip.org/files/content/priority-areas/coronavirus/FIP_Webinar_Coronavirus_response_20200210.pdf.
7.
Lucero-Prisno D3, Adebisi YA, Lin X. Current efforts and challenges facing responses to 2019-nCoV in Africa. Glob Health Res Policy. 2020;5:21. [PubMed ID: 32391440]. [PubMed Central ID: PMC7200322]. https://doi.org/10.1186/s41256-020-00148-1.
8.
Department of Health and Social Care. £300 million announced for community pharmacies to support them during coronavirus outbreak. 2020, [cited 2020 Apr 29]. Available from: https://www.gov.uk/government/news/300-million-announced-for-community-pharmacies-to-support-them-during-coronavirus-outbreak.
9.
Al-Quteimat Om Msc B, Amer Am R.Ph M. SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm. 2020. [PubMed ID: 32241695]. [PubMed Central ID: PMC7271257]. https://doi.org/10.1016/j.sapharm.2020.03.018.
10.
International Pharmaceutical Federation. FIP position statement on the association between the use of non-steroidal anti-inflammatory medicines (including ibuprofen), ACE inhibitors, angiotensin receptor blockers (ARBs) and corticosteroids, and an increased risk of coronavirus/COVID-19 infection or disease severity. 2020, [cited 2020 Jun 11]. Available from: https://www.fip.org/files/content/priority-areas/coronavirus/Other_FIP_resources/FIP-Position-Statement-COVID-19-medicines.pdf.
11.
Pharmacists oppose Covid-19 tax bill. 2020, [cited 2020 Apr 3]. Available from: https://www.nation.co.ke/business/Pharmacists-oppose-Covid-19-Tax-Bill/996-5535504-qphqw8/index.html. Accessed 3 April 2020.
12.
International Pharmaceutical Federation. Coronavirus/COVID-19 preparedness. [cited 2020 Apr 29]. Available from: https://www.fip.org/coronavirus.
13.
Pharmaceutical Group of European Union. Press release-community pharmacists in the frontline in the fight against the novel corona-virus disease (COVID-19). 2020, [cited 2020 Apr 29]. Available from: https://www.pgeu.eu/publications/press-release-community-pharmacists-in-the-frontline-in-the-fight-against-the-novel-corona-virus-disease-covid-19/.
14.
Bukhari N, Rasheed H, Nayyer B, Babar ZU. Pharmacists at the frontline beating the COVID-19 pandemic. J Pharm Policy Pract. 2020;13:8. [PubMed ID: 32328285]. [PubMed Central ID: PMC7168565]. https://doi.org/10.1186/s40545-020-00210-w.
15.
Adebisi YA, Oke GI, Ademola PS, Chinemelum IG, Ogunkola IO, Lucero-Prisno Iii DE. SARS-CoV-2 diagnostic testing in Africa: needs and challenges. Pan Afr Med J. 2020;35(Suppl 2):4. [PubMed ID: 32528615]. [PubMed Central ID: PMC7266476]. https://doi.org/10.11604/pamj.2020.35.4.22703.

comments